|
Cor-oticinDrug - Cor-oticin The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION/DROPS; OPHTHALMIC
Active Ingredient(s) -
Hydrocortisone Acetate; Neomycin Sulfate
Strength -
1.5%;EQ 3.5MG BASE/ML
Applicant -
AKORN
New Drug Application (NDA) Number -
060188
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Akorn Inc
Cor-oticin
Neo-cortef 0.5%;eq 3.5mg Base/gm Ointment; Ophthalmic
Neo-cortef 1.5%;eq 3.5mg Base/gm Ointment; Ophthalmic Neo-cortef 0.5%;eq 3.5mg Base/gm Ointment; Topical Neo-cortef 1%;eq 3.5mg Base/gm Ointment; Topical Neo-cortef 2.5%;eq 3.5mg Base/gm Ointment; Topical Cor-oticin 1.5%;eq 3.5mg Base/ml Suspension/drops; Ophthalmic Orabase Hca 0.5% Paste; Topical Hydrocortisone Acetate 100% Powder; For Rx Compounding Neo-cortef 1%;eq 3.5mg Base/gm Cream; Topical Neo-cortef 2.5%;eq 3.5mg Base/gm Cream; Topical NewDrugInformation |